EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access

Unmasking Risk Factors for Post–COVID-19 Olfactory Dysfunction Resulting From Early Stages of the Pandemic: A Case-Control Study of Lost and Lingering Smells

Brooke Stephanian iD, Jacob Hoerter iD, Julia Wei, Richard Pellizzari, Jonathan Liang

The Permanente Journal · 2025

DOI: 10.7812/tpp/25.010 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift The Permanente Journal, 2025. Verfasst von Brooke Stephanian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head & Neck Surgery, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA. Hauptthemen laut MEDLINE: COVID-19, Olfaction Disorders. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The COVID-19 pandemic has highlighted olfactory dysfunction (OD) as a major and often persistent symptom in affected individuals. Thus, it is important to identify demographic and clinical factors contributing to OD among patients with COVID-19. METHODS: A case-control (1:3) study was performed in adult patients with COVID-19 diagnosis between July 2020 and June 2021. Cases had OD; controls did not have OD. OD was subclassified as acute smell loss ( 3 months), or altered sense of smell (eg, parosmia, phantosmia). Bivariate tests and multivariable logistic regression were performed for analysis. RESULTS: Of the 4220 patients that met criteria, 1055 (25%) had OD. Of those with OD, 650 (61.6%) had acute smell reduction, 350 (33.2%) had chronic smell reduction, and 245 (23.2%) had altered sense of smell. Older (odds ratio [OR], 0.84; 95% confidence interval [CI], 0.79-0.89), male (OR, 0.62; 95% CI, 0.54-0.72), and Asian (OR 0.75; 95% CI, 0.59-0.95) patients were less likely to experience OD. Having seasonal allergies (OR, 1.44; 95% CI, 1.11-1.86) and being hospitalized (OR, 1.52; 95% CI, 1.14-2.02) increased the likelihood of OD development. Compared with acute loss, chronic smell loss was likelier in older, female, non-White, hospitalized, and cerebrovascular disease patients (P < .05). DISCUSSION: Understanding the course of post-COVID-19 OD is becoming increasingly important and may broaden these insights. CONCLUSION: Being younger, female, and atopic conferred highest likelihood of OD development after COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Olfaction DisordersHumansCase-Control StudiesFemaleMaleMiddle AgedRisk FactorsAgedAdultSARS-CoV-2

Autor:innen und Institutionen

  • Department of Otolaryngology-Head & Neck Surgery, Kaiser Permanente Oakland Medical Center, Oakland, CA, USA.
  • Department of Otolaryngology-Head & Neck Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Division of Otolaryngology-Head & Neck Surgery, Michigan State University College of Human Medicine, Grand Rapids, MI, USA.

ORCID-Profile: Brooke Stephanian, Jacob Hoerter

Zitieren

APA

Stephanian, B., Hoerter, J., Wei, J., Pellizzari, R., & Liang, J. (2025). Unmasking Risk Factors for Post–COVID-19 Olfactory Dysfunction Resulting From Early Stages of the Pandemic: A Case-Control Study of Lost and Lingering Smells. The Permanente Journal. https://doi.org/10.7812/tpp/25.010

Vancouver

Stephanian B, Hoerter J, Wei J, Pellizzari R, Liang J. Unmasking Risk Factors for Post–COVID-19 Olfactory Dysfunction Resulting From Early Stages of the Pandemic: A Case-Control Study of Lost and Lingering Smells. The Permanente Journal. 2025. doi:10.7812/tpp/25.010

BibTeX
@article{Stephanian2025,
  author = {Stephanian, Brooke and Hoerter, Jacob and Wei, Julia and Pellizzari, Richard and Liang, Jonathan},
  title = {Unmasking Risk Factors for Post–COVID-19 Olfactory Dysfunction Resulting From Early Stages of the Pandemic: A Case-Control Study of Lost and Lingering Smells},
  journal = {The Permanente Journal},
  year = {2025},
  doi = {10.7812/tpp/25.010}
}
Kostenlos starten →